Statistics for Surmodics (id:8109 SRDX)

Valuation metrics

Market cap

559.98M

Enterprise value

538.84M

Trailing P/E (ttm)

43.03

Forward P/E

140.18

PEG ratio

140.18

Price/Sales (ttm)

4.44

Price/Book (mrq)

4.68

Enterprise Value/Revenue

4.27

Enterprise Value/EBITDA

79.60

Overview

Shares outstanding

14.27M

Float

11.26M

Shares short

330.95K

% Held by insiders

0.04%

% Held by institutions

0.83%

Average volume (10 days)

205.36K

Average volume (90 days)

Price summary

52-Week low

25.17

52-Week high

42.44

52-Week change

13.56%

Beta

1.20

50-Day moving average

38.50

200-Day moving average

36.15

Dividends and splits

Forward annual dividend rate

Forward annual dividend yield

Trailing annual dividend rate

0.00%

Trailing annual dividend yield

0.00

5-Year annual dividend yield

Payout ratio

0.00

Dividend date

Ex-dividend date

Last split factor

2:1

Last split date

December 07th, 2000

Financials

Fiscal year

Fiscal year ends

September 30th, 2024

Most recent quarter (mrq)

June 30th, 2024

Profitability

Profit margin

-9.16%

Operating margin

-1.84%

Operational effectiveness

Return on assets

-0.66%

Return on equity

-9.67%

Income statement

Revenue (ttm)

8.91

Revenue per share (ttm)

8.91

Quarterly revenue growth (yoy)

Gross profit (ttm)

61.02M

EBITDA

14.95M

Net income to common (ttm)

-11,542,000.00

Diluted EPS (ttm)

-0.82

Quarterly earnings growth (yoy)

Balance sheet

Total cash (mrq)

40.11M

Total cash per share (mrq)

2.83

Total debt (mrq)

29.55M

Total Debt/Equity (mrq)

24.86

Current ratio (mrq)

395.80%

Book value per share (mrq)

8.38

Cash flow

Cash flow statement

248.00K

Levered free cash flow (LFCF)

7.61M